About the Company
Cyanotech Corporation, a world leader in microalgae technology for more than 30 years, produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. The Company's mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech's BioAstin® offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise*. Cyanotech's Spirulina products offer nutrition that supports cardiovascular health and immunity*. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe (GRAS) for use in food products. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to dietary supplement, nutraceutical and cosmeceutical manufacturers and marketers. The Company is regulated by the Food and Drug Administration ('FDA').
|Name||Ticker||Market Capitalization (USD M)||Revenue (USD M)||Price/Book||Price/Earning||Net Margin (%)|
|Conversion Labs Inc||CVLB||108548||35213||3.74||42.66||7.33|
|Royalty Pharma plc||RPRX||19327||2239||2.87||15.52||43.40|
|Organon & Co.||OGN||8644||7891||-4.46||4.95||22.06|
|ATAI Life Sciences N.V.||ATAI||2545||20||5.35||-11.65||-932.88|
|Cronos Group Inc||CRON||2114||57||1.33||-14.64||-258.59|
|Usana Health Sciences Inc||USNA||1837||1254||4.18||13.23||11.09|
|Phathom Pharmaceuticals Inc||PHAT||1178||7.99||-7.35||None|
|Fulcrum Therapeutics Inc||FULC||925||15||11.21||-12.53||-481.07|
|Intersect ENT Inc||XENT||899||103||21.80||-13.10||-66.55|
|Phibro Animal Health Corp.||PAHC||888||833||3.68||16.16||6.53|
|Edgewise Therapeutics Inc||EWTX||848||2.87||-31.45||None|
|Pliant Therapeutics Inc||PLRX||657||13||2.69||-7.66||-613.56|
|Cyteir Therapeutics Inc||CYT||637||3.42||-22.04||None|
|Urovant Sciences Ltd||UROV||503||-3.65||-3.08||None|
|Ikena Oncology Inc||IKNA||467||10||2.52||-8.53||-551.28|
|Rain Therapeutics Inc||RAIN||404||413||2.50||-13.27||123.20|
|Provention Bio Inc||PRVB||400||2.68||-3.12||None|
|Verrica Pharmaceuticals Inc||VRCA||316||12||6.41||-8.69||-301.45|
|Terns Pharmaceuticals Inc||TERN||263||1.46||-7.62||None|
|Adicet Bio Inc||ACET||230||9||1.00||-4.09||-603.06|
|Milestone Pharmaceuticals Inc||MIST||222||15||1.25||-7.50||-215.93|
|Kaleido Biosciences Inc||KLDO||222||1||4.94||-2.49||None|
|Kala Pharmaceuticals Inc||KALA||187||11||2.42||-1.48||None|
|Osmotica Pharmaceuticals Plc||OSMT||181||190||2.64||-1.95||-47.85|
|Citius Pharmaceuticals Inc||CTXR||177||2.21||-7.70||None|
|Aquestive Therapeutics Inc||AQST||146||42||-3.02||-2.27||-152.73|
|Eton Pharmaceuticals Inc||ETON||123||15||6.11||-10.06||-74.52|
|Odonate Therapeutics Inc||ODT||117||1.47||-1.00||None|
|Aerpio Pharmaceuticals Inc||ARPO||99||15||2.98||-5.24||-28.77|
|Opiant Pharmaceuticals Inc||OPNT||90||37||2.71||-86.08||-3.06|
|Natural Alternatives Internati||NAII||89||169||1.26||10.07||5.68|
|VYNE Therapeutics Inc||VYNE||72||16||1.08||3.27||-554.66|
|India Globalization Capital In||IGC||67||0||2.39||-7.65||-981.18|
|Acasti Pharma Inc||ACST||42||0||1.81||-2.11||-611.47|
|Assertio Holdings Inc||ASRT||33||117||0.45||-0.58||-38.05|
|Reviva Pharmaceuticals Holding||RVPH||30||1.64||-4.74||None|
|Baudax Bio Inc||BXRX||28||1||-11.98||0.84||None|
|Nabriva Therapeutics Plc||NBRV||28||12||0.83||-0.47||-452.55|
|Bio-Path Holdings Inc||BPTH||28||0||1.29||-2.68||18.96|
|Timber Pharmaceuticals Inc||TMBR||26||0||11.39||0.88||-527.55|
|Trevi Therapeutics Inc||TRVI||26||1.67||-0.74||None|
|Lexaria Bioscience Corp||LEXX||25||1||3.49||-6.45||-445.15|
|Hoth Therapeutics Inc||HOTH||22||1.85||-2.29||None|
|Sonoma Pharmaceuticals Inc.||SNOA||11||17||3.13||-2.04||-31.96|
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Looking at Cyanotech Corporation's (NASDAQ:CYAN ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders ...
Cyanotech's (NASDAQ:CYAN) stock up by 5.0% over the past week. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to investigate if the ...
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica ...
Global Marine Biotechnology Market Report - Production and Consumption Professional Analysis (Impact of COVID-19) is latest ...
Natural Spirulina Market Research Report 2021: Latest Innovations, Competitive Landscape, Business Growth Factors Industry Analysis by 2026
Global “Natural Spirulina Market” report provides a complete analysis of market size, share, growth drivers, challenges, competitive situation, trends and COVID-19 impact is covered in this report.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...